Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07892976) titled 'The CORE Platform Trial' on Oct. 19.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Copenhagen Trial Unit, Center for Clinical Intervention Research
Condition:
Coronary Revascularization
Coronary Artery Disease
Intervention:
Procedure: MIDCAB procedure
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: January 1, 2027
Target Sample Size: 15000
Countries of Recruitment:
Belgium
Denmark
Netherlands
Belgium
Denmark
Netherlands
To know more, visit...